| Migraine |
1 |
1 |
| Headache |
0 |
1 |
| Tryptamine |
0 |
0.59 |
| Blood Vessel |
0 |
0.55 |
| Blood |
0 |
0.44 |
| Increased Blood Pressure |
0 |
0.34 |
| Receptors |
0 |
0.29 |
| Adverse Effects |
0 |
0.26 |
| Patient Safety |
0 |
0.19 |
| Insurance |
0 |
0.18 |
| Pain |
0 |
0.18 |
| Abdominal Pain |
0 |
0.15 |
| Nausea |
0 |
0.15 |
| Nerve |
0 |
0.15 |
| Otolaryngology |
0 |
0.15 |
| Pain Management |
0 |
0.15 |
| Revenue and Practice Management |
0 |
0.15 |
| Sleep |
0 |
0.15 |
| Disability |
0 |
0.11 |
| Obesity |
0 |
0.1 |
| Diet |
0 |
0.07 |
| Dizziness |
0 |
0.07 |
| Exercise |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Monoclonal Antibody |
0 |
0.07 |
| Nonpharmacologic |
0 |
0.07 |
| Intravenous |
0 |
0.06 |
| Medication Overuse Headache (MOH) |
0 |
0.06 |
| Biologic Therapy |
0 |
0.05 |
| Constipation |
0 |
0.05 |
| Abdomen |
0 |
0.04 |
| Antifungal |
0 |
0.04 |
| Aspirin |
0 |
0.04 |
| Beta-Adrenergic Agonist |
0 |
0.04 |
| Brain |
0 |
0.04 |
| Cerebrovascular Disease |
0 |
0.04 |
| Cervical Region |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Cluster Headaches |
0 |
0.04 |
| Drug Costs |
0 |
0.04 |
| Food and Drug Administration (FDA) |
0 |
0.04 |
| Health Administration |
0 |
0.04 |
| Jobs |
0 |
0.04 |
| Liver |
0 |
0.04 |
| Metabolism |
0 |
0.04 |
| Mouth |
0 |
0.04 |
| Nasal Mucosa |
0 |
0.04 |
| Nose |
0 |
0.04 |
| Antibiotics |
0 |
0.02 |
| Cerebrovascular Accident |
0 |
0.02 |
| Epilepsy |
0 |
0.02 |
| Fungal Infection |
0 |
0.02 |
| Healthcare and Medical Technology |
0 |
0.02 |
| Hypertension |
0 |
0.02 |
| Insomnia |
0 |
0.02 |
| Sleep Disorders |
0 |
0.02 |